Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer

A phase II trial was performed to determine the antitumour efficacy and tolerance of combined paclitaxel and cisplatin with or without hematopoetic growth factor support in patients with advanced gastric cancer. Forty-five patients with histologically confirmed metastatic gastric cancer were entered...

Descripción completa

Detalles Bibliográficos
Autores principales: Kornek, G V, Raderer, M, Schüll, B, Fiebiger, W, Gedlicka, C, Lenauer, A, Depisch, D, Schneeweiss, B, Lang, F, Scheithauer, W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375443/
https://www.ncbi.nlm.nih.gov/pubmed/12085176
http://dx.doi.org/10.1038/sj.bjc.6600345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375443/
https://www.ncbi.nlm.nih.gov/pubmed/12085176
http://dx.doi.org/10.1038/sj.bjc.6600345

Ejemplares similares